Mergers & Acquisitions Mergers & Acquisitions

Comment: Fewer deals clearing high EU bar for phase I remedies highlights enforcers’ focus

By Andrew Boyce
  • 28 Dec 2023 15:04
  • 28 Dec 2023 15:04
The EU’s merger regulator this year approved just four deals with remedies at the initial stage of review — the lowest number on record since 1997.
That in part reflects a drop in global dealmaking due to the economic climate, but it stems perhaps even more from fears of increasingly

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Andrew Boyce

Correspondent


Andrew is a reporter covering merger reviews and competition policy for MLex in Brussels. He joined MLex in 2015 and holds a degree and a master’s degree in history from the University of Liverpool.

Discover MLex

Stay on top of global regulatory developments

Latest News